OGEN

Actualités Oragenics

Nom Action Symbole Action Marché Type
Oragenics Inc OGEN AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,2418 3,77% 6,6618 19:05:54
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,27 6,27 6,7399 6,42
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
26/1/202312:04EDGARNotice of Effectiveness (effect)
13/1/202322:22EDGARSecurities Registration Statement (simplified Form) (s-3)
23/12/202222:20EDGARCurrent Report Filing (8-k)
23/12/202222:05BWOragenics, Inc. Discloses One-for-Sixty Reverse Stock Split
22/12/202215:01EDGARCurrent Report Filing (8-k)
22/12/202213:30BWOragenics Reports Favorable Toxicology Results for its..
20/12/202222:57EDGARCurrent Report Filing (8-k)
20/12/202222:36BWOragenics, Inc. Receives NYSE American Notice
19/12/202222:52EDGARCurrent Report Filing (8-k)
19/12/202222:34BWOragenics, Inc. Announces New Chair
16/12/202222:07EDGARCurrent Report Filing (8-k)
16/12/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
15/12/202222:15EDGARStatement of Changes in Beneficial Ownership (4)
12/12/202222:23EDGARStatement of Changes in Beneficial Ownership (4)
09/12/202222:15EDGARStatement of Changes in Beneficial Ownership (4)
16/11/202222:16EDGARCurrent Report Filing (8-k)
14/11/202222:57EDGARQuarterly Report (10-q)
24/10/202222:01BWOragenics to Participate in the 2022 BioFlorida Annual..
03/10/202215:16EDGARCurrent Report Filing (8-k)
30/9/202215:01EDGARCurrent Report Filing (8-k)
30/9/202213:30BWOragenics Issues Letter to Shareholders
24/8/202213:00BWOragenics Announces Favorable Preliminary Toxicology Data..
09/8/202222:08EDGARQuarterly Report (10-q)
03/8/202222:06EDGARCurrent Report Filing (8-k)
02/8/202222:42EDGARStatement of Changes in Beneficial Ownership (4)
29/7/202222:03EDGARAmended Annual Report (10-k/a)
08/7/202222:05EDGARCurrent Report Filing (8-k)
27/6/202222:10EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
24/6/202222:16EDGARStatement of Changes in Beneficial Ownership (4)
24/6/202222:16EDGARStatement of Changes in Beneficial Ownership (4)
24/6/202222:16EDGARStatement of Changes in Beneficial Ownership (4)
23/6/202223:23EDGARCurrent Report Filing (8-k)
23/6/202222:30BWOragenics Appoints Seasoned Vaccine Executive Kimberly..
21/6/202215:31EDGARStatement of Changes in Beneficial Ownership (4)
14/6/202213:30BWOragenics Announces Publication of Positive Data for its..
20/5/202222:16EDGARStatement of Changes in Beneficial Ownership (4)
17/5/202215:31EDGARCurrent Report Filing (8-k)
17/5/202213:30BWOragenics Issues Letter to Shareholders
13/5/202222:38EDGARQuarterly Report (10-q)
19/4/202223:14EDGARCurrent Report Filing (8-k)
18/4/202213:30BWOragenics to Participate at the World Vaccine Congress..
06/4/202216:47SEEKOragenics extends collaboration deal to develop vaccines..
06/4/202213:45EDGARCurrent Report Filing (8-k)
06/4/202213:30BWOragenics Extends Collaboration to Develop Vaccines against..
01/4/202222:06EDGARStatement of Changes in Beneficial Ownership (4)
25/3/202219:14SEEKOragenics drops after flagging audit concerns
25/3/202212:30BWOragenics, Inc. Receives Audit Opinion with Going Concern..
24/3/202221:23EDGARSecurities Registration: Employee Benefit Plan (s-8)
22/3/202215:25SEEKOragenics begins toxicology study in animals to test..
22/3/202213:59BWOragenics Initiates a Pivotal IND-Enabling Toxicology Study..
Dernières Valeurs Consultées
AMEX
OGEN
Oragenics
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

Se connecter à ADVFN
S'inscrire maintenant

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20230202 18:24:51